American Chemical Society hosts ACS GCI Pharmaceutical Roundtable spring meeting

The spring meeting of the American Chemical Society Green Chemistry Institute (GCI) Pharmaceutical Roundtable was held April 9–11 at ACS headquarters in Washington, DC. The roundtable gathers for three in-person meetings each year to advance its mission of enabling innovation through the integration of green chemistry and green engineering in the pharmaceutical industry supply chain and allied industries, such as agriculture and animal health. The 2024 spring meeting brought together industry representatives from more than 45 companies in person and virtually and was the roundtable’s first time convening for an annual meeting at ACS headquarters.

Albert G. Horvath, ACS CEO, welcomed and thanked members for their contributions to the ACS mission and highlighted the importance of international collaborations throughout the industry. The meeting included discussions led by the roundtable management team on new research funding opportunities, emergent federal-level chemical regulations, potential collaboration with academia and nongovernmental organizations, and the promotion of the roundtable’s many green chemistry tools and metrics. With the roundtable’s 20th anniversary approaching next year, the group aims to strengthen its partnerships while continuing to make progress toward more sustainable manufacturing of bioactive molecules.